Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial

June 30, 2025

View Press Release Corporate presentation Contact us
Previous